Effects of Information Provided by Pharmacists on Pharmacotherapy
10.11256/jjdi.15.105
- VernacularTitle:薬剤師による医薬品適正使用情報提供が薬物治療に及ぼす影響
- Author:
Mariko Kawana
;
Yuka Kobori
;
Masahito Nakazaki
;
Masanori Suzuki
;
Junko Nagai
;
Tadanori Sasaki
- Publication Type:Journal Article
- Keywords:
aliskiren;
pharmacists;
drug information;
effectiveness;
safety
- From:Japanese Journal of Drug Informatics
2013;15(3):105-110
- CountryJapan
- Language:English
-
Abstract:
Objective: There are only a few studies evaluating the effects of drug information services on pharmacotherapy. We, therefore, studied the effects of providing drug information such as the effectiveness and safety of aliskiren on its pharmacotherapeutic efficacy by comparing before versus after drug information provision.
Methods: Pharmacists provided drug information such as the effectiveness and safety of aliskiren coadministered with either ACE-I (angiotensin converting enzyme inhibitor) or ARB (angiotensin receptor blocker) to physicians and other healthcare professionals. We compared the number of patients for whom aliskiren was prescribed, the proportion of diabetic patients taking both aliskiren and ACE-I (or ARB), the proportion of patients with low eGFR (estimated glomerular filtration rate), and the proportion of patients with hyperkalemia and related conditions, before versus after providing the drug information to the healthcare professionals.
Results: The number of patients for whom aliskiren was prescribed decreased. The proportion of patients taking both aliskiren and ACE-I (or ARB) decreased significantly after providing the drug information (p=0.007). The proportion of diabetic patients taking both aliskiren and ACE-I (or ARB), the proportion of patients with low eGFR, and the proportion of patients with hyperkalemia also decreased, after providing the drug information.
Conclusion: This study showed the drug information service to be clinically beneficial, achieving better pharmacotherapy. Pharmacists should evaluate and provide information on the effectiveness and safety of drugs announced by authorities in a timely manner to achieve optimal patient care.
